Background

The Affordable Care Act includes a 40% excise tax on employer-sponsored health plans with annual premiums exceeding $10,200 for individuals or $27,500 for families (the amount exceeding the threshold is taxed at 40%). Most predictions indicate that a significant number of group health plans would trigger the 40 percent excise tax if there aren’t any adjustments made to the threshold. This has been dubbed the “Cadillac Tax” referring to high-cost health plans.

Implementation was scheduled for 2018, but at the end of 2015, Congress delayed the effective date to 2020. The 2018 tax reform legislation delayed the Cadillac Tax until 2022.

The Issue

This “Cadillac Tax” on health plans was intended to serve as an incentive for employers to minimize costly health plans in an effort to curb healthcare spending. Supporters of the tax predicted doing so would decrease costs and increase taxable wages as employers shift funds from health plans to salaries. The Congressional Budget Office (CBO) estimated that the tax would generate $87 billion in revenue, expecting about $22 billion to be realized from payment of the tax, and $65 billion to be realized from new taxable income projected from an employee compensation shift from benefits to salaries.

However, there are several issues coming to fruition. The tax’s threshold is tied to the Consumer Price Index (CPI) and does not take into account medical inflation. Plans that were considered high-cost, generous or extravagant are or will be the standard as premiums and healthcare costs continue to rise. This will subject a large percentage of employer sponsored health plans to the tax. Council member firms estimate the tax could impact nearly 80% of all employer health plans by 2020. Many employers will not be able to bear the extra cost which will force them to drop coverage altogether for employees.

Further, studies show that employers are not shifting funds from health plans to compensation significantly reducing the expected revenue from predicted increases in compensation. Studies also continue to show that healthcare costs are rising faster than wages and this trend shows no signs of reversing. Ultimately the tax is creating a financial burden and strain for employees and their families.

Our Position

The Council urges Congress to fully repeal the Cadillac Tax.

All Healthcare Issues

December 20, 2019 – HHS Releases Final Rule on Oversight and “Integrity” of State-Based Exchanges

HHS issued a final rule that aims to strengthen oversight of state-based exchanges and ensure accurate eligibility determinations for premium subsidies.

December 20, 2019 – Federal Healthcare Reform and Drug Pricing Tracker

Our legal team at Steptoe & Johnson is tracking healthcare reform bills as they are introduced in the 116th Congress. The tracker is updated as of December 20.

December 18, 2019 – Trump Administration Releases Two Proposals to Provide Pathways for Drug Importation

The FDA released two proposals that would offer additional avenues through which drugs could be imported into the United States and sold at lower prices in the U.S. market.

December 10, 2019 – House Committee Convenes Hearing on Universal Healthcare Proposals

The House Energy and Commerce Subcommittee on Health held a hearing to discuss nine proposals aimed at expanding health insurance coverage across the country.

November 18, 2019 New Study on Public Option Reveals Impact to Individual Market

A new study released by FTI Consulting and the Partnership for America’s Health Care Future assesses the impact of a public option on market stability and consumer choice in the ACA marketplaces.